NCT07199946View on ClinicalTrials.gov

A Phase I/II Trial to Preserve Residual Insulin Secretion in Children With Recent Onset Type 1 Diabetes by Giving Verapamil

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

May 31, 2030

Conditions
Type 1 Diabetes
Interventions
DRUG

Verapamil (Part A)

Verapamil 3-6mg/kg body weight and 24 hrs

DRUG

Placebo

Placebo given in part B, the comparator arm of the double blind randomized trial

Trial Locations (2)

Unknown

NOT_YET_RECRUITING

Pediatric Clinic , Ryhovs hospital, Jönköping

SE58185

RECRUITING

Crown Princess Victoria Children´s Hospital, University Hospital, Linköping

All Listed Sponsors
collaborator

Region Östergötland

OTHER

collaborator

Region Jönköping County

OTHER_GOV

lead

Johnny Ludvigsson

OTHER_GOV